Clinical trial
Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid…
NCT00435851 · Gustave Roussy, Cancer Campus, Grand Paris, Other · Unknown status
Key facts
| NCT number | NCT00435851 |
|---|---|
| Title | Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid Carcinoma Patients |
| Official title | Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid Carcinoma Patients - Estimabl |
| Acronym | Estimabl |
| Lead sponsor | Gustave Roussy, Cancer Campus, Grand Paris, Other |
| Collaborators | National Cancer Institute, France |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Thyroid Cancer |
| Intervention type | Drug |
| Interventions | Thyrogen, thyroid hormone withdrawal, iode 131 |
| Enrollment | 950 |
| Start date | Feb 1, 2007 |
| First posted | Feb 16, 2007 |
| Last update posted | Feb 19, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: